Pure Red Cell Aplasia with M-Gradient: A Literature Review and Clinical Experience

Background. Pure red cell aplasia (PRCA) is a rare syndrome characterized by a decrease of erythroid progenitor cell count in the bone marrow. M-gradient with both a light and a heavy chain types in PRCA patients is a rare phenomenon which is considered to be a specific form of the disease.

Aim. To review a clinical presentation, diagnostic capabilities, and treatment outcomes of PRCA with M-gradient.

Materials & Methods. The analysis included 10 patients. The most effective empirically established treatment program was 200–400 g of cyclophosphamide 2–3 times a week to a total dose of 6–10 g and loading courses of 100–120 mg of oral and 180–240 mg of intravenous prednisone daily within 5 days. On the 6th day prednisone injections were discontinued, and from the 7th day the oral dose of prednisone was gradually reduced to permanent discontinuation in 2–3 days. This treatment course was repeated 1–3 times at intervals of a week. Targeted enzyme immunoassay of M-gradient was performed in 4 patients in order to determine whether M-gradient is the sum of two antibody types, i.e. erythrokaryocyte antibodies and secondary anti-idiotype antibodies against primary antibodies.

Results. The total of 6 out of 10 PRCA patients reached complete remission within the period from 9 months to 22 years of follow-up, in 4 patients no remission was achieved. M-gradient contained IgG (n = 9) and IgA (n = 1) oligoclones. In typing it consisted of IgGλ (n = 4), IgGκ (n = 5) and IgAκ (n = 1). M-gradient enzyme immunoassay showed no primary and secondary anti-idiotype antibodies.

Conclusion. The obtained results allow to regard gammopathy in PRCA as an effect of oligoclonal hyper-immunoglobulin without any pathogenetic connection between M-gradient and PRCA.

• Aleksandr Vasil’evich Pivnik RUDN University, 6 Miklukho-Maklaya str., Moscow, Russian Federation, 117198; AS Loginov Moscow Clinical Scientific Center, 89 Entuziastov sh., Moscow, Russian Federation, 111123 ; Российский университет дружбы народов, ул. Миклухо-Маклая, д. 6, Москва, Российская Федерация, 117198; ГБУЗ «Московский клинический научный центр им. А.С. Логинова ДЗМ», ш. Энтузиастов, д. 86, Москва, Российская Федерация, 111123
• A.A. Petrenko RUDN University, 6 Miklukho-Maklaya str., Moscow, Russian Federation, 117198 ; Российский университет дружбы народов, ул. Миклухо-Маклая, д. 6, Москва, Российская Федерация, 117198
• S.V. Kozhurin National Medical Hematology Research Center, 4a Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167 ; ФГБУ «НМИЦ гематологии» Минздрава России, Новый Зыковский пр-д, д. 4а, Москва, Российская Федерация, 125167
• S.A. Mar’ina National Medical Hematology Research Center, 4a Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167 ; ФГБУ «НМИЦ гематологии» Минздрава России, Новый Зыковский пр-д, д. 4а, Москва, Российская Федерация, 125167

1. Japson JH, Lovenstein L. Panhypoplasia in the bone marrow. 1. Demonstration of a plasma factor with anti-erythropoietin-like activity. Can Med Assoc J. 1968;99(3):99–101. DOI: https://doi.org/10.1136/bmj.3.5610.99
2. Гериатрическая гематология. Заболевания системы крови в старших возрастных группах. Под ред. Л.Д. Гриншпун, А.В. Пивника. М.: Медиум, 2012. Т. 2. С. 438–41.[Grinshpun LD, Pivnik AV, eds. Geriatricheskaya gematologiya. Zabolevaniya sistemy krovi v starshikh vozrastnykh gruppakh. (Geriatric hematology. Blood disorders in elderly patients.) Moscow: Medium Publ.; 2012, vol. 2. pp. 438–41. (In Russ)]
3. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood. 1996;87(11):4831–8. DOI: https://doi.org/10.1182/blood.V87.11.4831.bloodjournal87114831
4. Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood. 1996;87(7):3000–6. DOI: https://doi.org/10.1182/blood.V87.7.3000.bloodjournal8773000
5. Руководство по гематологии. Под ред. А.И. Воробьева. 3-е изд. перераб. и доп. М.: Ньюдиамед, 2005. Т. 3. С. 274–85.[Vorob’ev AI, ed. Rukovodstvo po gematologii. (Guidelines on hematology.) 3rd revised edition. Moscow: Newdiamed Publ.; 2005, vol. 3. pp. 274–85. (In Russ)]
6. Идельсон Л.И., Тер-Григоров B.C., Пивник A.B., Эткин А.Ф. Клинико-иммунологические особенности парциальной красноклеточной аплазии сочетанной с моноклональной гаммапатией. Терапевтический архив. 1983;8:75–9.[Idel’son LI, Ter-Grigorov VC, Pivnik AV, Etkin AF. Clinical and immunological profile of pure red cell aplasia together with monoclonal gammopathy. Terapevticheskii arkhiv. 1983;8:75–9. (In Russ)]
7. Пивник А.В. Парциальная красноклеточная аплазия костного мозга: клиника, вопросы патогенеза, диагностика, лечение: Дис. … канд. мед. наук. М., 1978.[Pivnik AV. Partsial’naya krasnokletochnaya aplaziya kostnogo mozga: klinika, voprosy patogeneza, diagnostika, lechenie. (Pure red cell aplasia in bone marrow: clinical presentation, pathogenesis, diagnostics, treatment.) [dissertation] Moscow; 1978. (In Russ)]
8. Андреева Н.Е., Чернохвостова Е.В. Иммуноглобулинопатии. М.: Медицина, 1985. 240 c.[Andreeva NE, Chernokhvostova EV. Immunoglobulinopatii. (Immunoglobulinopathy.) Moscow: Meditsina Publ.; 1985. 240 p. (In Russ)]
9. Эткин А.Ф., Пивник А.В., Мамиляева З.Х. Олигоклональная парапротеинемия при парциальной аплазии костного мозга. Гематология и трансфузиология. 1987;4:31–4.[Etkin AF, Pivnik AV, Mamilyaeva ZKh. Oligoclonal paraproteinemia in partial red cell aplasia in the bone marrow. Gematologiya i transfuziologiya. 1987;4:31–4. (In Russ)]
10. Kobayashi T, Hanada T, Sato Y, et al. A case of pure red cell aplasia with monoclonal gammopathy: immune-mediated inhibition of erythropoiesis. Rinsho Ketsueki. 1987;28(11):2029–33.
11. Balducci L, Hardy C, Dreiling B, et al. Pure red blood cell aplasia associated with paraproteinemia: in vitro studies of erythropoiesis. Haematologia (Budap). 1984;17(3):353–7.
12. Gu H, Lee WI, Jeon Y, et al. Pure Red Cell Aplasia Associated with Monoclonal Gammopathy of Undetermined Significance and Literature Review. Clin Lab. 2017;63(2):373–8. doi: 10.7754/Clin.Lab.2016.160730. DOI: https://doi.org/10.7754/Clin.Lab.2016.160730
13. Murate T, Ohashi H, Ichikawa A, et al. A case of pure red cell aplasia with monoclonal gammopathy. Nihon Naika Gakkai Zasshi. 1992;81(8):1263–5. DOI: https://doi.org/10.2169/naika.81.1263
14. Shimmyozu K, Tara M, Okadome T, et al. Pure red cell aplasia with monoclonal gammopathy and von Willebrand disease. Rinsho Ketsueki. 1990;31(9):1468–73.
15. Korde N, Zhang Y, Loeliger K, et al. Monoclonal gammopathy-associated pure red cell aplasia. Br J Haematol. 2016;173(6):876–83. doi: 10.1111/bjh.14012. DOI: https://doi.org/10.1111/bjh.14012
16. Идельсон Л.И., Койфман М.М., Горина Л.Г., Оловников А.М. Применение агрегат-гемагглютинационной пробы и других методов для диагностики аутоиммунной гемолитической анемии с отрицательной прямой пробой Кумбса. Проблемы гематологии. 1975;6:91–9.[Idel’son LI, Koifman MM, Gorina LG, Olovnikov AM. Application of an aggregate-hemagglutination test and other assays for the diagnosis of autoimmune hemolytic anaemia with a negative direct antiglobulin test. Problemy gematologii. 1975;6:91–9. (In Russ)]